Chinares Pharma (03320) announced the performance of KPC Pharmaceuticals, Inc. for the nine months ended September 30, 2024, with total operating income...
According to the Zhitong Finance App, Chinares Pharma (03320) announced the performance of KPC Pharmaceuticals, Inc. for the nine months ended September 30, 2024, with total operating income of 5.457 billion yuan (RMB, same below), a decrease of 2.73% year-on-year; net income of 0.391 billion yuan, a decrease of 1.44% year-on-year.